Opvee (nalmefene), is an intranasal opioid antagonist used for opioid overdose and was approved by the FDA in 2023. This approval provided another tool to aid in combating the opioid crisis. There are currently two medications, Opvee and Narcan (naloxone), that can...
In this blog post, I want to share some important SSRI clinical pearls that help clinicians decide which of these antidepressants to use. Note that these clinical practice pearls are good examples of some testable items that may show up on your board exam 🙂 Sertraline...
We will compare aripiprazole versus risperidone and why a clinician might recommend one versus another. These two agents are two of the most commonly used antipsychotics in practice. Antipsychotics are most often used for psychiatric disorders like schizophrenia and...
Paroxetine is from the family of SSRIs (selective serotonin reuptake inhibitors. It has been around for a long time and is indicated for depression, anxiety, and many other psychiatric indications just like other SSRIs. It doesn’t get much love from healthcare...
I’ve encountered a significant proportion of patients who are on chronic benzodiazepines. Drug interactions, adverse effects, and other risks to my geriatric patient population are significant when using this class of medication. Benzodiazepine withdrawal is...
Bupropion (Wellbutrin) is an antidepressant that is most commonly used as an alternative (or sometimes in combination) to SSRIs. In this post, I will share my most important bupropion clinical pearls as well as some things that may show up on your board exam! Seizure...
